EFFECTIVENESS OF EARLY INFORMATION AND ENDORSMENT BY GP TO INCREASE COLONOSCOPY FOLLOW-UP AND REDUCE DELAYS IN PEOPLE WITH A POSITIVE COLORECTAL CANCER SCREENING TEST. (SUIVICOLO)
About this study
To be effective, organized colorectal cancer screening requires good adherence to diagnostic colonoscopy in the event of a positive test. In France, the rate of diagnostic colonoscopy following a positive colorectal cancer screening test is less than 85%, and the median delay is close to 90 days. After receiving their positive result from the laboratory, individuals with no known follow-up are contacted only six months later by the Regional Cancer Screening Coordination Centers (CRCDC) responsible for following up with individuals who have tested positive. To optimize follow-up with colonoscopy, earlier contact and information about colonoscopy appear to be necessary. The contribution of the general practitioner identified on the test could be an additional lever. The SUIVICOLO study aims to evaluate the effectiveness on the rate of colonoscopies performed at 6 months of two strategies for optimizing the follow-up of positive results in comparison with control group C (current procedures of the CRCDC Centre Val de Loire without early letter). The two strategies evaluated will be: * Group B1: Sending an early letter signed by the CRCDC accompanied by information leaflet about colonoscopy * Group B2: Sending an early letter co-signed by the CRCDC and the general practitioner (identified or provided by the patient on the test identification form) accompanied by information leaflet about colonoscopy. These strategies will be compared to the current follow-up strategy in a three arm randomized controlled arm.
- Condition
- Colorectal Cancer Screening
- Tested
- Usual care follow-up by CRCDC, Information leaflet about colonoscopy follow-up, Endorsement of CRCDC letters from the GP
- Sponsor
- University Hospital, Caen
Who can join
- Age
- 50 to 75 years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 8
- Minimum age: 50 years
- Maximum age: 75 years
- Study condition: Colorectal Cancer Screening
- Aged between 50 and 75 at the time of the positive colorectal cancer screening test
- Residing in one of the departments of the Centre Val de Loire region
- Date on which the positive CRC screening test result was sent to the beneficiary recorded
- Colorectal cancer screening test results sent to the beneficiary within 30 days of the test being read
- Affiliated with a health insurance fund
Exclusion 1
- Subjects who have notified their refusal to allow their data to be used for research purposes will be excluded from the analyses.
Where
1 site, 1 recruiting
Crcdc-Cvl
Tours, France, France
Contact
-
Lydia GUITTET, MD,PhD
231065781 lydia.guittet@unicaen.fr
-
Arnaud ALVES, MD,PhD
231065781 alves-a@chu-caen.fr
Potential match only. Final eligibility is determined by the study team.